Neonatal purpura fulminans in association with factor V R506Q mutation

Journal of Pediatrics

Volumn 128, Issue 5 I, 1996, Pages 706-709

  Pipe, S W ^a   Schmaier, A H ^a   Nichols, W C ^a   Ginsburg, D ^a   Bozynski, M E A ^a   Castle, V P ^a  

^a Box 0684   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FULMINATING PURPURA; GENE MUTATION; HUMAN; INFANT; NEWBORN DISEASE; PRIORITY JOURNAL; PURPURA; SKIN DEFECT;

EID: 0030005015     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)80142-9     Document Type: Article

References (17)

1. Marlar R.A. Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies Semin Thromb Hemost 16 1990 299 309
2. Francis R.B.J. Acquired purpura fulminans Semin Thromb Hemost 16 1990 310 325
3. Marlar R.A. Montgomery R.R. Broekmans A.W. Diagnosis and treatment of homozygous Protein C-deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommitte on Protein C and Protein S, International Committee on Thrombosis and Haemostasis J Pediatr 114 1989 528 534
4. Mahasandana C. Suvatte V. Marlar R.A. Manco-Johnson M.J. Jacobson L.J. Hathaway W.E. Neonatal purpura fulminans associated with homozygous protein S deficiency Lancet 335 1990 61 62
5. Andrew M. Paes B. Milner R. Development of the human coagulation system in the full-term infant Blood 70 1987 165 172
6. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood 85 1995 607 614
7. Ridker P.A. Hennekens C.H. Lindpaintner K. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men N Engl J Med 332 1994 912 917
8. Svensson P.J. Dahlback B. Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
9. Bertina R.M. Koeleman B.P. Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
10. Zoller B. Svensson P.J. He X. Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521 2524
11. Sun X. Evatt B. Griffin J.H. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia Blood 83 1994 3120 3125
12. Koeleman B.P. Reitsma P.H. Allaart C.F. Bertina R.M. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families Blood 84 1994 1031 1035
13. Fernandez J.A. Estelles A. Gilabert J. Espana F. Aznar J. Functional and immunologic protein S in normal pregnant women and in full-teen newborns Thromb Haemost 61 1989 474 478
14. Shen L. Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa J Biol Chem 269 1994 18735 18738
15. Dahlback B. Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant co-factor activity found to be a property of factor V Proc Nail Acad Sci U S A 91 1994 1396 1400
16. Smak Gregoor P.J. Harvey M.S. Briet E. Brand A. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees for 28 days Transfusion 33 1993 735 739
17. Kodish E. Potter C. Kirschbaum N.E. Foster P.A. Activated protein C resistance in a neonate with venous thrombosis J Pediatr 127 1995 645 648